Home Newsfeeds Vaxcyte Q3 EPS $(0.93) Down From $(0.51) YoY

Vaxcyte Q3 EPS $(0.93) Down From $(0.51) YoY

Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(0.93) per share. This is a 82.35 percent decrease over losses of $(0.51) per share from the same period last year.

byBenzinga Newsdesk

November 7, 2022

1 minute read

Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(0.93) per share. This is a 82.35 percent decrease over losses of $(0.51) per share from the same period last year.

State Street Q3: EPS Beat, Revenue Misses Consensus On Portfolio Restructuring Losses & More

By Lekha Gupta

October 18, 9:46 AM

State Street Corporation (NYSE: STT) reported Q3 revenues of $2.69 billion, down 9% Y/Y,

STT

News

‘A TikTok Ban Is Inevitable And That Spells Trouble For U.S. Stocks, Gene Munster Says’ – Business Insider

By Happy Mohamed

March 24, 10:48 AM

https://markets.businessinsider.com/news/stocks/tiktok-ban-china-tech-stocks-tesla-apple-meta-gene-munster-2023-3 A TikTok ban is bound to happen eventually, according to Deepwater's Gene Munster. He pointed to

AMZN

Trodelvy Demonstrates Efficacy Treating Both Platinum-Ineligible And Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer

By Happy Mohamed

February 17, 10:01 AM

– Oral Presentation Highlights Trodelvy Efficacy of 13.5 Months Overall Survival in Patients with Platinum-Ineligible Metastatic UC After Checkpoint Inhibitor Therapy – – Trodelvy Demonstrated

GILD

Gov. Lujan Grisham and Array Technologies Announce New Mexico Expansion; The State Has Awarded Array $2.5M In Economic Assistance From The Local Economic Development Act

By Benzinga Newsdesk

November 2, 9:06 AM

Gov. Michelle Lujan Grisham and Array Technologies CEO Kevin Hostetler announced today that Array Technologies (NASDAQ:ARRY) ("Array" or "the Company") has finalized plans for a major expansion that will solidify the

ARRY

Vaxcyte Q3 EPS $(0.93) Down From $(0.51) YoY

Related Posts

State Street Q3: EPS Beat, Revenue Misses Consensus On Portfolio Restructuring Losses & More

‘A TikTok Ban Is Inevitable And That Spells Trouble For U.S. Stocks, Gene Munster Says’ – Business Insider

Trodelvy Demonstrates Efficacy Treating Both Platinum-Ineligible And Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer

Gov. Lujan Grisham and Array Technologies Announce New Mexico Expansion; The State Has Awarded Array $2.5M In Economic Assistance From The Local Economic Development Act